FDA Inspection 1210690 — Lonza Biologics, Inc.
The FDA completed an inspection of Lonza Biologics, Inc. on Jul 21, 2023 in Portsmouth, NH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 21, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Portsmouth, NH (United States)